Literature DB >> 33431894

Antagomir-mediated suppression of microRNA-134 reduces kainic acid-induced seizures in immature mice.

Aoife Campbell1,2, Gareth Morris1,2, Janosch P Heller1,2,3, Elena Langa1,2, Elizabeth Brindley1, Jesper Worm4, Mads Aaboe Jensen4, Meghan T Miller5, David C Henshall6,7,8, Cristina R Reschke1,2.   

Abstract

MicroRNAs are short non-coding RNAs that negatively regulate protein levels and perform important roles in establishing and maintaining neuronal network function. Previous studies in adult rodents have detected upregulation of microRNA-134 after prolonged seizures (status epilepticus) and demonstrated that silencing microRNA-134 using antisense oligonucleotides, termed antagomirs, has potent and long-lasting seizure-suppressive effects. Here we investigated whether targeting microRNA-134 can reduce or delay acute seizures in the immature brain. Status epilepticus was induced in 21 day-old (P21) male mice by systemic injection of 5 mg/kg kainic acid. This triggered prolonged electrographic seizures and select bilateral neuronal death within the CA3 subfield of the hippocampus. Expression of microRNA-134 and functional loading to Argonaute-2 was not significantly changed in the hippocampus after seizures in the model. Nevertheless, when levels of microRNA-134 were reduced by prior intracerebroventricular injection of an antagomir, kainic acid-induced seizures were delayed and less severe and mice displayed reduced neuronal death in the hippocampus. These studies demonstrate targeting microRNA-134 may have therapeutic applications for the treatment of seizures in children.

Entities:  

Year:  2021        PMID: 33431894      PMCID: PMC7801672          DOI: 10.1038/s41598-020-79350-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  40 in total

Review 1.  Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence.

Authors:  Giovanni Laviola; Simone Macrì; Sara Morley-Fletcher; Walter Adriani
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

Review 2.  Structural and functional brain networks: from connections to cognition.

Authors:  Hae-Jeong Park; Karl Friston
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

3.  Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll).

Authors:  A Nagy; A V Delgado-Escueta
Journal:  J Neurochem       Date:  1984-10       Impact factor: 5.372

4.  The prevalence and incidence of convulsive disorders in children.

Authors:  W A Hauser
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

Review 5.  Predicting pharmacoresistance in pediatric epilepsy.

Authors:  Elaine C Wirrell
Journal:  Epilepsia       Date:  2013-05       Impact factor: 5.864

Review 6.  MicroRNAs in epilepsy: pathophysiology and clinical utility.

Authors:  David C Henshall; Hajo M Hamer; R Jeroen Pasterkamp; David B Goldstein; Jørgen Kjems; Jochen H M Prehn; Stephanie Schorge; Kai Lamottke; Felix Rosenow
Journal:  Lancet Neurol       Date:  2016-12       Impact factor: 44.182

7.  Spared CA1 pyramidal neuron function and hippocampal performance following antisense knockdown of microRNA-134.

Authors:  Gareth Morris; Gary P Brennan; Cristina R Reschke; David C Henshall; Stephanie Schorge
Journal:  Epilepsia       Date:  2018-07-05       Impact factor: 5.864

8.  Noninflammatory Changes of Microglia Are Sufficient to Cause Epilepsy.

Authors:  Xiaofeng Zhao; Yuan Liao; Shannon Morgan; Ramkumar Mathur; Paul Feustel; Joseph Mazurkiewicz; Jiang Qian; Julia Chang; Gary W Mathern; Matthew A Adamo; Anthony L Ritaccio; Michael Gruenthal; Xinjun Zhu; Yunfei Huang
Journal:  Cell Rep       Date:  2018-02-20       Impact factor: 9.423

9.  Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus.

Authors:  Marika Nosten-Bertrand; Caroline Kappeler; Céline Dinocourt; Cécile Denis; Johanne Germain; Françoise Phan Dinh Tuy; Soraya Verstraeten; Chantal Alvarez; Christine Métin; Jamel Chelly; Bruno Giros; Richard Miles; Antoine Depaulis; Fiona Francis
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

10.  Differential RISC association of endogenous human microRNAs predicts their inhibitory potential.

Authors:  Omar Flores; Edward M Kennedy; Rebecca L Skalsky; Bryan R Cullen
Journal:  Nucleic Acids Res       Date:  2014-01-23       Impact factor: 16.971

View more
  3 in total

Review 1.  Epigenetic genes and epilepsy - emerging mechanisms and clinical applications.

Authors:  Karen M J Van Loo; Gemma L Carvill; Albert J Becker; Karen Conboy; Alica M Goldman; Katja Kobow; Iscia Lopes-Cendes; Christopher A Reid; Erwin A van Vliet; David C Henshall
Journal:  Nat Rev Neurol       Date:  2022-07-20       Impact factor: 44.711

2.  AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome.

Authors:  Aoife Campbell; Gareth Morris; Albert Sanfeliu; Joana Augusto; Elena Langa; Jaideep C Kesavan; Ngoc T Nguyen; Ronan M Conroy; Jesper Worm; Lukasz Kielpinski; Mads Aaboe Jensen; Meghan T Miller; Thomas Kremer; Cristina R Reschke; David C Henshall
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-20       Impact factor: 10.183

3.  Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome.

Authors:  Rogério R Gerbatin; Joana Augusto; Gareth Morris; Aoife Campbell; Jesper Worm; Elena Langa; Cristina R Reschke; David C Henshall
Journal:  eNeuro       Date:  2022-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.